Organelle-Targeted Nanocarriers: Specific Delivery of Liposomal Ceramide to Mitochondria Enhances Its Cytotoxicity in Vitro and in Vivo
- 9 July 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 8 (8), 2559-2563
- https://doi.org/10.1021/nl801908y
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Organelle-specific targeting in drug delivery and designAdvanced Drug Delivery Reviews, 2007
- Liposomes and Liposome-like Vesicles for Drug and DNA Delivery to MitochondriaJournal of Liposome Research, 2006
- Glycerol enhances radiosensitivity in a human oral squamous cell carcinoma cell line (Ca9-22) bearing a mutant p53 gene via Bax-mediated induction of apoptosisOral Oncology, 2005
- Systemic Delivery of Liposomal Short-Chain Ceramide Limits Solid Tumor Growth in Murine Models of Breast AdenocarcinomaClinical Cancer Research, 2005
- Mitochondriotropic LiposomesJournal of Liposome Research, 2005
- Mitochondrial pharmaceuticsMitochondrion, 2004
- Cellular Distribution of Nonionic MicellesScience, 2004
- Enlargement and Contracture of C2-Ceramide ChannelsBiophysical Journal, 2003
- Mitochondria Transfection by Oligonucleotides Containing a Signal Peptide and Vectorized by Cationic LiposomesAntisense and Nucleic Acid Drug Development, 2001
- SYNTHESIS, CHARACTERIZATION, AND BIOLOGICAL PROPERTIES OF A FULLERENE TRIPHENYLPHOSPHONIUM SALTFullerene Science and Technology, 2001